Product Pathways - Apoptosis
SignalSilence® Puma siRNA II #12890
|12890S||300 µl (3 nmol)||---||In Stock||---|
|12890||carrier free and custom formulation / quantity||email request|
Already purchased this product? Write a Review.
Species predicted to react based on 100% sequence homology: Monkey.
Western blot analysis of extracts from A549 cells, transfected with 100 nM SignalSilence® Control siRNA (Unconjugated) #6568 (-), SignalSilence® Puma siRNA I #12845 (+), or SignalSilence® Puma siRNA II (+), using Puma (D30C10) Rabbit mAb #12450 (upper) or β-Actin (D6A8) Rabbit mAb #8457 (lower). The Puma (D30C10) Rabbit mAb confirms silencing of Puma expression, while the β-Actin (D6A8) Rabbit mAb is used as a loading control.
SignalSilence® Puma siRNA II from Cell Signaling Technology (CST) allows the researcher to specifically inhibit Puma expression using RNA interference, a method whereby gene expression can be selectively silenced through the delivery of double stranded RNA molecules into the cell. All SignalSilence® siRNA products from CST are rigorously tested in-house and have been shown to reduce target protein expression by western analysis.
Oligonucleotide synthesis is monitored base by base through trityl analysis to ensure appropriate coupling efficiency. The oligo is subsequently purified by affinity-solid phase extraction. The annealed RNA duplex is further analyzed by mass spectrometry to verify the exact composition of the duplex. Each lot is compared to the previous lot by mass spectrometry to ensure maximum lot-to-lot consistency.
Directions For Use
CST recommends transfection with 100 nM SignalSilence® Puma siRNA II 48 to 72 hours prior to cell lysis. For transfection procedure, follow protocol provided by the transfection reagent manufacturer. Please feel free to contact CST with any questions on use.
Each vial contains the equivalent of 100 transfections, which corresponds to a final siRNA concentration of 100 nM per transfection in a 24-well plate with a total volume of 300 μl per well.
Puma (p53 upregulated modulator of apoptosis) is a "BH3-only" Bcl-2 family member originally identified in differential gene expression studies as a p53-inducible gene (1,2). The "BH3-only" family members include Bad, Bid, Bik, Hrk, Bim, and Noxa, all of which contain a BH3 domain but lack other conserved domains, BH1 and BH2, and generally promote apoptosis by binding to and antagonizing anti-apoptotic Bcl-2 family members through BH3 domain interactions (3). Two BH3-containing proteins are produced from the puma gene, Puma-α and Puma-β, both of which are induced by p53, bind Bcl-2 and Bcl-xL, localize to the mitochondria, and promote cyctochrome c release and apoptosis (1,2). Puma plays a critical role in the p53 tumor suppressor pathway. Targeted disruption of the puma gene impairs p53-mediated apoptosis and tumor suprression (4-7). Puma knockout mice show defects from multiple apoptotic stimuli, including ionizing irradiation, deregulated c-Myc expression, and cytokine withdrawal (4).
- Yu, J. et al. (2001) Mol. Cell 7, 673-682.
- Nakano, K. and Vousden, K.H. (2001) Mol. Cell 7, 683-694.
- Bouillet, P. and Strasser, A. (2002) J. Cell Sci. 115, 1567-1574.
- Jeffers, J.R. et al. (2003) Cancer Cell 4, 321-328.
- Hemann, M.T. et al. (2004) Proc. Natl. Acad. Sci. USA 101, 9333-9338.
- Yu, J. et al. (2003) Proc. Natl. Acad. Sci. USA 100, 1931-1936.
- Villunger, A. et al. (2003) Science 302, 1036-1038.
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
For Research Use Only. Not For Use In Diagnostic Procedures.
SignalSilence® is a trademark of Cell Signaling Technology, Inc.
Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.